ArticleTherapeutic advances in hematology2025

The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia.

Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.